Brazilian evidence-based guideline for screening, diagnosis, treatment, and follow-up of metabolic dysfunction-associated steatotic liver disease (MASLD) in adult individuals with overweight or obesity: A joint position statement from the Brazilian Society of Endocrinology and Metabolism (SBEM), Brazilian Society of Hepatology (SBH), and Brazilian Association for the Study of Obesity and Metabolic Syndrome (Abeso).
Arch Endocrinol Metab
; 67(6): e230123, 2023 Nov 27.
Article
en En
| MEDLINE
| ID: mdl-38048417
Palabras clave
Texto completo:
1
Bases de datos:
MEDLINE
Asunto principal:
Síndrome Metabólico
/
Enfermedad del Hígado Graso no Alcohólico
/
Gastroenterología
/
Enfermedades Metabólicas
Límite:
Adult
/
Humans
País/Región como asunto:
America do sul
/
Brasil
Idioma:
En
Revista:
Arch Endocrinol Metab
Año:
2023
Tipo del documento:
Article